Sorry, you need to enable JavaScript to visit this website.

RELPAX® (eletriptan hydrobromide) Indications and Usage

1 INDICATIONS AND USAGE

RELPAX is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use:

  • Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with RELPAX, reconsider the diagnosis of migraine before RELPAX is administered to treat any subsequent attacks.
  • RELPAX is not intended for the prevention of migraine attacks.
  • Safety and effectiveness of RELPAX have not been established for cluster headache.

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for RELPAX®